pharmaceutical investing La Jolla Pharmaceutical Company Gets European Commission Approval for GIAPREZA
pharmaceutical investing La Jolla Pharmaceutical Company Receives Orphan Designation from FDA for LJPC-0118
pharmaceutical investing La Jolla Pharmaceutical Company Announces U.S. FDA’s Grant of Breakthrough Therapy Designation for LJPC-0118
pharmaceutical investing La Jolla Pharmaceutical Company Announces European Medicines Agency Validation of Marketing Authorisation Application for GIAPREZA
Gemdale Gold Intersects 5.19m at 14.01 g/t Au within 110m at 1.18 g/t Au at the Pontio Gold Project, Finland
Transition Metals Expands Gowganda Gold Project to 125 Square-kilometres in Ontario's Abitibi Greenstone Belt
